Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Jellinger

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 5, 2002
Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropicsM Rainer, H A Mucke, C Krüger-Rainer, et al.
Acta Neuropathologica|November 9, 2001
Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical studyN Embacher, W A Kaufmann, R Beer, et al.
Acta Neuropathologica|August 30, 2000
Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's diseaseJ Marksteiner, T Lechner, W A Kaufmann, et al.
Advances in Neurology|January 1, 1993
Iron and ferritin in substantia nigra in Parkinson's diseaseK A Jellinger, E Kienzl, G Rumpelmaier, et al.
Neuropathology and Applied Neurobiology|October 19, 2012
Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matterK E McAleese, M Firbank, D Hunter, et al.
Neurology|February 11, 2012
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer diseaseM Watabe-Rudolph, Z Song, L Lausser, et al.
Neurology|November 1, 1996
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopI G McKeith, D Galasko, K Kosaka, et al.
European Journal of Neurology|April 15, 2009
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment optionsA C Ludolph, J Kassubek, B G Landwehrmeyer, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 5, 2002
Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropicsM Rainer, H A Mucke, C Krüger-Rainer, et al.
Acta Neuropathologica|November 9, 2001
Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical studyN Embacher, W A Kaufmann, R Beer, et al.
Acta Neuropathologica|August 30, 2000
Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's diseaseJ Marksteiner, T Lechner, W A Kaufmann, et al.
Advances in Neurology|January 1, 1993
Iron and ferritin in substantia nigra in Parkinson's diseaseK A Jellinger, E Kienzl, G Rumpelmaier, et al.
Neuropathology and Applied Neurobiology|October 19, 2012
Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matterK E McAleese, M Firbank, D Hunter, et al.
Neurology|February 11, 2012
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer diseaseM Watabe-Rudolph, Z Song, L Lausser, et al.
Neurology|November 1, 1996
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopI G McKeith, D Galasko, K Kosaka, et al.
European Journal of Neurology|April 15, 2009
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment optionsA C Ludolph, J Kassubek, B G Landwehrmeyer, et al.
Pageof 13